Brendan F Boyce

Optimizing the use and applications of special stains: clinical and experimental approaches

Brendan F Boyce, 2012, Biotechnic & histochemistry : official publication of the Biological Stain Commission.

Remodeling of cortical bone allografts mediated by adherent rAAV-RANKL and VEGF gene therapy

Hiromu Ito, Brendan F Boyce, Kirill Gromov, 2005, Nature Medicine.

Defining inflammatory cell states in rheumatoid arthritis joint synovial tissues by integrating single-cell transcriptomics and mass cytometry

Nir Hacohen, Kamil Slowikowski, Andrew Filer, 2019, Nature Immunology.

Biology of RANK, RANKL, and osteoprotegerin

Brendan F Boyce, L. Xing, B. Boyce, 2007, Arthritis research & therapy.

NF‐κB p50 and p52 Expression Is Not Required for RANK‐Expressing Osteoclast Progenitor Formation but Is Essential for RANK‐ and Cytokine‐Mediated Osteoclastogenesis

Ulrich Siebenlist, Brendan F Boyce, Timothy P Bushnell, 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Regulation of bone remodeling and emerging breakthrough drugs for osteoporosis and osteolytic bone metastases.

William Shakespeare, Brendan F Boyce, L. Xing, 2003, Kidney international. Supplement.